BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Yulex Corporation Closes Series B Financing Round Totaling $4.5 Million


10/19/2005 5:11:05 PM

CARLSBAD, Calif., April 28 /PRNewswire/ -- Yulex, a materials science company pioneering a domestic source of natural rubber latex for hypoallergenic medical devices and specialty consumer products, announced today the completion of its Series B round of financing totaling $4.5 million.

Argonaut Private Equity led the financing, providing $2.0 million in February 2003, the proceeds of which were used for the building of a commercial pilot facility for the production of Guayule-based (why-you-lee) natural rubber latex and expanding its plantations in Arizona and California. Yulex completed construction of the pilot production facility in July 2003 and is currently growing guayule on several plantations throughout the desert southwestern United States.

The History Channel will feature Yulex and its Guayule plantations in a June 9 airing of its Modern Marvels program that traces rubber's history and examines its role in shaping modern industrial society.

"With the additional funds, we are expanding our infrastructure for product development and will focus on accelerating product life cycles for select medical devices," says Jeffrey A. Martin, president and chief executive officer of Yulex. "Our initial product focus is on catheters, condoms, and medical gloves, where there has been no cost-effective solution to the problems of latex allergy."

Guayule is a desert plant indigenous to the southwestern United States, and a new industrial crop. Guayule-based or domestic latex is the only commercially available natural rubber alternative that is free of tropical proteins known to cause Type I latex allergy. With the advent of latex barrier products, especially in the medical industry, since the emergence of AIDS as a public health crisis, tropical latex sensitivities and allergies have come to affect over 20 million people.

Yulex (http://www.yulex.com/) is materials science company focused on the production of a domestic source of natural rubber derived from the desert plant known as Guayule. Yulex has an exclusive license to a patented process to produce latex and products from Guayule in cooperation with the U.S. Department of Agriculture. The Company, along with industrial strategic partners, is currently developing technology to extract other specialty chemicals and biofuels from the desert plant. Yulex, a privately-held company, was founded in 1997 and based in Carlsbad, California.

For further information, please contact: Jeffrey Martin, President and CEO of Yulex Corporation, +1-760-476-0320, jmartin@yulex.com; or Julie Wright of (W)right On Communications, +1-760-735-9411, jwright@wrightoncomm.com .

Yulex Corporation

CONTACT: Jeffrey Martin, President and CEO of Yulex Corporation,+1-760-476-0320, jmartin@yulex.com; or Julie Wright of (W)right OnCommunications, +1-760-735-9411, jwright@wrightoncomm.com


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->